Cy3 Goat Anti-Human IgG (H+L) Antibody: Precision in Human IgG Detection

Principle and Setup: Foundations of Sensitive Immunoglobulin Detection

The Cy3 Goat Anti-Human IgG (H+L) Antibody is purpose-built for advanced human immunoglobulin detection across multiple immunoassays. This polyclonal goat anti-human IgG antibody is affinity-purified to ensure high specificity for human IgG heavy and light chains, minimizing cross-reactivity and background noise—a critical need for translational research and clinical diagnostics. The conjugation with Cy3, a bright and photostable fluorescent dye (excitation 552 nm/emission 565 nm), enables direct visualization and quantitation of human IgG via fluorescence microscopy, flow cytometry, and plate-based assays.

As a fluorescent secondary antibody for human IgG detection, this reagent is indispensable for workflows where signal amplification, multiplexing, and quantitative accuracy are essential. Its broad reactivity with all human IgG subclasses (IgG1, IgG2, IgG3, IgG4) and minimal cross-reactivity with non-human proteins ensure it serves as a universal secondary antibody for immunofluorescence (ICC/IF), immunohistochemistry (IHC-Fr and IHC-P), flow cytometry, and ELISA.

Step-by-Step Workflow Enhancements: Protocol Integration

1. Immunofluorescence Assay (ICC/IF)

• Sample Preparation: Fix cells with 4% paraformaldehyde; permeabilize with 0.1% Triton X-100 as needed.
• Blocking: Incubate with 5% BSA or normal goat serum to prevent non-specific binding.
• Primary Antibody Incubation: Apply human primary antibody against the target antigen (e.g., anti-M1R or anti-B6R from recent orthopoxvirus studies).
• Secondary Antibody Incubation: Incubate with Cy3 Goat Anti-Human IgG (H+L) Antibody (1–5 μg/mL) in the dark for 1 hour at room temperature.
• Imaging: Wash thoroughly and mount with anti-fade reagent. Capture images using Cy3-appropriate filter sets.

This workflow delivers high signal-to-noise ratios—often yielding >15-fold fluorescence over background as reported in comparative analyses (see published workflow solutions).

2. Immunohistochemistry (IHC-Fr/IHC-P)

• Deparaffinize and rehydrate tissue sections or prepare frozen tissues as per standard protocols.
• Antigen retrieval may be performed for paraffin-embedded samples (e.g., citrate buffer, pH 6.0, 20 min at 95°C).
• Block and incubate with human primary antibody, followed by Cy3 Goat Anti-Human IgG (H+L) Antibody (optimized at 1–2 μg/mL).
• Counterstain nuclei with DAPI and visualize under a fluorescence microscope.

As a robust immunohistochemistry secondary antibody, the product enhances tissue-specific detection, enabling multiplexed analyses when combined with other spectrally distinct secondary antibodies.

3. Flow Cytometry Applications

• Stain cell suspensions with human primary antibody, wash, then incubate with Cy3-conjugated secondary antibody (0.5–2 μg/10⁶ cells).
• Use appropriate compensation controls when multiplexing with FITC, PE, or APC dyes.
• Acquire and analyze data using cytometers equipped with a 532–561 nm laser line.

Quantitative flow cytometry studies have shown consistent detection sensitivity at sub-nanogram levels of human IgG, making it an ideal secondary antibody for flow cytometry in immune profiling and therapeutic antibody validation (see multiplexing strategies).

4. ELISA: Quantitative Detection

• Coat plates with antigen, block, and incubate with human IgG-containing samples.
• Apply Cy3 Goat Anti-Human IgG (H+L) Antibody (0.1–2 μg/mL) for detection.
• Read fluorescence with a plate reader (excitation/emission: 550/570 nm).

This Cy3 labeled antibody for ELISA achieves picogram-level detection limits, supporting quantitative immunoglobulin G detection in clinical or research settings (see quantitative application insights).

Advanced Applications and Comparative Advantages

Multiplexing and Signal Amplification

The Cy3 Goat Anti-Human IgG (H+L) Antibody’s polyclonal nature allows for multiple binding events on each primary antibody, dramatically increasing signal output—a key advantage for low-abundance target detection. Its compatibility with other fluorophores enables simultaneous detection of multiple analytes, supporting advanced multiplex immunofluorescence and flow cytometry panels.

This property was instrumental in recent orthopoxvirus antibody mapping studies, where the detection of anti-M1R and anti-B6R monoclonal antibodies facilitated precise epitope characterization and bispecific antibody design, crucial for developing broad-spectrum therapeutics against mpox and related viruses.

Comparison to Alternative Detection Strategies

When benchmarked against enzymatic detection systems (e.g., HRP or AP-conjugated antibodies), Cy3-conjugated secondary antibodies offer:

• Superior multiplexing: No substrate crosstalk; simultaneous multi-color detection.
• Quantitative robustness: Linear fluorescence response across a wide dynamic range for reliable quantitation.
• Workflow efficiency: Shorter assay times (no substrate incubation) and fewer wash steps.

For a detailed analysis of signal amplification and workflow optimization, see the advanced signal amplification review. This complements the protocol-driven solutions outlined above and highlights the antibody’s versatility for next-generation immunodetection systems.

Troubleshooting and Optimization Tips

• High Background: Ensure adequate blocking (5% BSA, normal goat serum), minimize primary antibody concentration, and optimize washing stringency.
• Weak Signal: Confirm primary antibody specificity and concentration; increase secondary antibody incubation time; avoid over-fixation of cells/tissues.
• Photobleaching: Protect slides and antibody solutions from light at all stages. Use anti-fade mounting media for fluorescence microscopy.
• Storage and Stability: Upon receipt, aliquot the antibody and store at -20°C, protected from light. Avoid more than three freeze-thaw cycles to preserve integrity and fluorescence signal. The antibody remains stable for up to 12 months under these conditions.
• Multiplexing: Employ proper compensation and spectral separation controls in flow cytometry and multiplex IF to avoid channel overlap.

For reproducibility and troubleshooting case studies, the article Enhancing Immunoassay Reliability provides scenario-driven solutions that complement the recommendations above.

Future Outlook: Expanding the Utility of Cy3-Conjugated Secondary Antibodies

The demand for signal amplification antibodies and fluorescent dye conjugated antibodies in precision medicine, infectious disease monitoring, and immunotherapy development continues to grow. The Cy3 Goat Anti-Human IgG (H+L) Antibody is uniquely positioned to meet these evolving needs, especially as translational research integrates more complex multiplex assays and quantitative immunoprofiling technologies.

Recent advances—such as the characterization and bispecific design of anti-M1R/B6R antibodies for mpox therapy—demonstrate the critical role of reliable secondary detection in infectious disease research. As antibody-based therapeutics expand, the need for robust, photostable, and highly specific secondary antibodies for biomedical research will only intensify.

For researchers seeking to push the boundaries of protein detection and immune profiling, APExBIO’s Cy3 Goat Anti-Human IgG (H+L) Antibody offers a proven, versatile, and scalable solution that integrates seamlessly into established and emerging immunodetection workflows.

Conclusion

The Cy3 Goat Anti-Human IgG (H+L) Antibody from APExBIO stands as a benchmark fluorescent secondary antibody for human IgG detection, supporting workflows from immunofluorescence to quantitative ELISA. Its affinity purification, Cy3 dye conjugation, and proven performance in multiplexed and quantitative applications make it an essential immunodetection reagent for both routine and cutting-edge biomedical research. Explore complementary resources for protocol specifics, signal amplification strategies, and application-driven guidance to optimize your next immunoassay project.